Cargando…
The role of leukotriene modifying agent treatment in neuropsychiatric events of elderly asthma patients: a nested case control study
BACKGROUND: In March 2020, the US Food and Drug Administration decided that the dangers related to neuropsychiatric events (NPEs) of montelukast, one of the leukotriene modifying agents (LTMAs), should be communicated through ‘boxed warning’. In case of NPEs, the prevalence has been the highest in e...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972201/ https://www.ncbi.nlm.nih.gov/pubmed/33731203 http://dx.doi.org/10.1186/s40733-021-00070-4 |